Clinical Trial Update: Safety and Efficacy of Induced Pluripotent Stem Cell-derived Engineered Human Myocardium as Biological Ventricular Assist Tissue in Terminal Heart Failure [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating the safety and preliminary efficacy of induced pluripotent stem cell–derived engineered human myocardium as a biological ventricular …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Engineered human myocardium (iPSC-derived) biological ventricular assist tissue

Snippet

Sponsor: University Medical Center Goettingen | Conditions: Heart Failure | Phase 1, Phase 2 | Status: RECRUITING